GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Joincare Pharmaceutical Group Industry Co Ltd (SHSE:600380) » Definitions » Equity-to-Asset

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Equity-to-Asset : 0.41 (As of Mar. 2025)


View and export this data going back to 2001. Start your Free Trial

What is Joincare Pharmaceutical Group Industry Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Joincare Pharmaceutical Group Industry Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥14,645 Mil. Joincare Pharmaceutical Group Industry Co's Total Assets for the quarter that ended in Mar. 2025 was ¥35,769 Mil. Therefore, Joincare Pharmaceutical Group Industry Co's Equity to Asset Ratio for the quarter that ended in Mar. 2025 was 0.41.

The historical rank and industry rank for Joincare Pharmaceutical Group Industry Co's Equity-to-Asset or its related term are showing as below:

SHSE:600380' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26   Med: 0.38   Max: 0.45
Current: 0.41

During the past 13 years, the highest Equity to Asset Ratio of Joincare Pharmaceutical Group Industry Co was 0.45. The lowest was 0.26. And the median was 0.38.

SHSE:600380's Equity-to-Asset is ranked worse than
74.76% of 1022 companies
in the Drug Manufacturers industry
Industry Median: 0.61 vs SHSE:600380: 0.41

Joincare Pharmaceutical Group Industry Co Equity-to-Asset Historical Data

The historical data trend for Joincare Pharmaceutical Group Industry Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joincare Pharmaceutical Group Industry Co Equity-to-Asset Chart

Joincare Pharmaceutical Group Industry Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.39 0.38 0.37 0.38 0.41

Joincare Pharmaceutical Group Industry Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.39 0.40 0.41 0.41

Competitive Comparison of Joincare Pharmaceutical Group Industry Co's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Joincare Pharmaceutical Group Industry Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Joincare Pharmaceutical Group Industry Co's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Joincare Pharmaceutical Group Industry Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Joincare Pharmaceutical Group Industry Co's Equity-to-Asset falls into.


;
;

Joincare Pharmaceutical Group Industry Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Joincare Pharmaceutical Group Industry Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Equity to Asset (A: Dec. 2024 )=Total Stockholders Equity/Total Assets
=14534.72/35718.129
=0.41

Joincare Pharmaceutical Group Industry Co's Equity to Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

Equity to Asset (Q: Mar. 2025 )=Total Stockholders Equity/Total Assets
=14644.946/35768.906
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Joincare Pharmaceutical Group Industry Co  (SHSE:600380) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Joincare Pharmaceutical Group Industry Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Joincare Pharmaceutical Group Industry Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Joincare Pharmaceutical Group Industry Co Business Description

Traded in Other Exchanges
N/A
Address
No. 17, Langshan Road, North District, High-tech Zone, Nanshan District, Guangdong, Shenzhen, CHN, 518057
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
Executives
Xie You Guo Supervisors
Yu Xiong Directors, senior managers
Zhao Feng Guang senior management
Qiu Qing Feng Directors, senior managers
Tang Ling Zhi senior management
Lin Nan Qi Directors, senior managers
Cao Ping Wei Director
Feng Yan Fang Director
Zhong Shan senior management
Yang Dong Yun senior management
Peng Jin Hua Supervisors
Guo Xiao Yun Supervisors
Su Qing Wen senior management

Joincare Pharmaceutical Group Industry Co Headlines

No Headlines